OKUR
Financials
- Market Capitalization 153.48 M
- Employee 45
- Founded 2011
- CEO N/A
- Website www.onkuretherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00JVRSRC1
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3145 |  UPB Upstream Bio, Inc. - Common Stock | 6.69 USD | -1.47% | -4.43% | +5.35% | -59.84% | 366.42 M USD | ||
| 3336 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 13.97 USD | -0.71% | -0.85% | -1.13% | -10.22% | 295.09 M USD | ||
| 3926 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.06 USD | -2.37% | -0.96% | +1.98% | -95.42% | 102.68 M USD | ||
| 3966 |  PTHS Pelthos Therapeutics Inc. Common Stock | 24.46 USD | -2.28% | -3.13% | -5.78% | +3.78% | 93.64 M USD |
Frequently asked questions about OnKure Therapeutics, Inc. Class A Common Stock
What is the OnKure Therapeutics, Inc. Class A Common Stock stock price today?
The current price of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) is 3.79. Over the past 24 hours, the stock has changed by -1.04%. Follow the OKUR chart for real-time price dynamics.
What is the stock ticker of OnKure Therapeutics, Inc. Class A Common Stock?
OnKure Therapeutics, Inc. Class A Common Stock trades under the ticker OKUR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is OnKure Therapeutics, Inc. Class A Common Stock stock going up?
OKUR has changed by -5.49% over the last week, -3.56% over the last month, and +54.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of OnKure Therapeutics, Inc. Class A Common Stock?
OnKure Therapeutics, Inc. Class A Common Stock currently has a market capitalization of 153.48 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were OnKure Therapeutics, Inc. Class A Common Stock earnings last quarter?
Last quarter, OnKure Therapeutics, Inc. Class A Common Stock reported earnings of -0.31 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was OnKure Therapeutics, Inc. Class A Common Stock revenue for the last quarter?
OnKure Therapeutics, Inc. Class A Common Stock reported quarterly revenue of 1.55 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was OnKure Therapeutics, Inc. Class A Common Stock net income for the last quarter?
OnKure Therapeutics, Inc. Class A Common Stock reported net income of -15.35 M for the last quarter. The previous quarter showed -15.16 M, which means net income changed by -1.25%.
How many employees does OnKure Therapeutics, Inc. Class A Common Stock have?
As of the latest available data, OnKure Therapeutics, Inc. Class A Common Stock has 45 employees. Workforce size can provide additional context about the company's scale and operations.
What is OnKure Therapeutics, Inc. Class A Common Stock EBITDA?
OnKure Therapeutics, Inc. Class A Common Stock EBITDA is -15.26 M, and its EBITDA margin is -982.55%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy OnKure Therapeutics, Inc. Class A Common Stock stock?
You can buy OnKure Therapeutics, Inc. Class A Common Stock (OKUR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in OnKure Therapeutics, Inc. Class A Common Stock stock?
Investing in OnKure Therapeutics, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OKUR chart and related analysis on metatrader.com as part of your research.